DAVID CAO: Open Payments
NPI 1437758653 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 16 payments from 10 companies in 2025. Trend: 2023 $1,655 · 2024 $1,057 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Amgen Inc. | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Averitas Pharma Inc. | 1 | $41 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
Products named: t:slim X2 Insulin Pump with Control-IQ, LEQVIO, TEPEZZA, GVOKE HYPOPEN, QUTENZA, TRYNGOLZA, MOUNJARO, MINIMED 780G.
Industry payments across CA — which companies pay providers there.
